February 20, 2015
Natcher Center at the National Institutes of Health (NIH) Campus
Bethesda, MD
Event Website: Click here
The Food and Drug Administration (FDA) is announcing a public Workshop
entitled: “Optimizing FDA’s Regulatory Oversight of Next Generation
Sequencing Diagnostic Tests.” The purpose of this workshop is to discuss
and receive feedback from the community on FDA’s regulatory approach to
diagnostic tests for human genetics or genomics using Next Generation
Sequencing (NGS) technology.
PMC members shape and advance the future of personalized medicine.
Join Today